Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: SGE1 Interpretation
1
Mar 14, 2008 10:42AM
1
Mar 14, 2008 11:20AM
1
Mar 14, 2008 11:29AM

Mar 14, 2008 11:50AM

A 50/50 venture with TPL would not be out of the question and, if structured like PDS, would be most interesting. I still don't see TPL wanting to come under the full scrutiny of a public company. Why have this clause unless...?

I'm all for your outright acquistion.

 

 

Be well

 

Share
New Message
Please login to post a reply